Organigram Holdings Management

Management criteria checks 4/4

Organigram Holdings' CEO is Beena Goldenberg, appointed in Sep 2021, has a tenure of 2.67 years. total yearly compensation is CA$721.58K, comprised of 71.5% salary and 28.5% bonuses, including company stock and options. directly owns 0.001% of the company’s shares, worth $2.65K. The average tenure of the management team and the board of directors is 2.7 years and 4.3 years respectively.

Key information

Beena Goldenberg

Chief executive officer

CA$721.6k

Total compensation

CEO salary percentage	71.5%
CEO tenure	2.7yrs
CEO ownership	0.001%
Management average tenure	2.7yrs
Board average tenure	4.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Beena Goldenberg's remuneration changed compared to Organigram Holdings's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2023	CA$722k	CA$516k	-CA$229m
May 31 2023	n/a	n/a	-CA$222m
Feb 28 2023	n/a	n/a	-CA$11m
Nov 30 2022	n/a	n/a	-CA$8m
Aug 31 2022	CA$2m	CA$441k	-CA$14m

Compensation vs Market: Beena's total compensation ($USD524.45K) is below average for companies of similar size in the US market ($USD1.62M).

Compensation vs Earnings: Beena's compensation has been consistent with company performance over the past year.

CEO

Beena Goldenberg (59 yo)

2.7yrs

Tenure

CA$721,577

Compensation

Ms. Beena G. Goldenberg, ICD D, has been Chief Executive Officer of OrganiGram Holdings Inc. since September 9, 2021 and as its Director since November 19, 2021. Ms. Goldenberg has been Independent Directo...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Beena Goldenberg	CEO & Director	2.7yrs	CA$721.58k	0.0012% CA$ 2.7k
Helen Martin	Chief Legal Officer & Corporate Secretary	5.2yrs	CA$422.59k	no data
Timothy Emberg	Chief Commercial Officer	1.6yrs	CA$429.42k	no data
Paolo De Luca	Chief Strategy Officer	less than a year	CA$418.95k	0.016% CA$ 35.5k
Greg Guyatt	Chief Financial Officer	less than a year	no data	no data
Nathalie Batten	Senior Vice President of Operations	2.9yrs	no data	no data
Geoff Riggs	Chief Information Officer	1.8yrs	no data	no data
Max Schwartz	Director of Investor Relations	no data	no data	no data
Megan McCrae	Senior Vice President of Marketing & Communications	3yrs	no data	no data
Katrina McFadden	Chief People Officer	1.8yrs	no data	0.00026% CA$ 570.4
Gregory Engel	Special Advisor	3yrs	CA$893.95k	no data
Larry Rogers	Vice President of International Business Development	6.6yrs	CA$222.73k	no data

2.7yrs

Average Tenure

54yo

Average Age

Experienced Management: OGI's management team is considered experienced (2.7 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Beena Goldenberg	CEO & Director	2.5yrs	CA$721.58k	0.0012% CA$ 2.7k
Marjorie Wieshofer	Independent Director	3.3yrs	CA$167.50k	0.0024% CA$ 5.3k
Peter Amirault	Independent Chairman	7.9yrs	CA$236.92k	0.039% CA$ 84.9k
Stephen Smith	Independent Director	4.3yrs	CA$176.88k	0.0025% CA$ 5.5k
Dexter D. John	Independent Director	5.4yrs	CA$180.00k	0.0015% CA$ 3.2k
Geoffrey Machum	Independent Director	4.3yrs	CA$173.75k	0.0011% CA$ 2.4k
Sherry Porter	Independent Director	5.4yrs	CA$173.75k	0.0047% CA$ 10.4k
Simon Ashton	Independent Director	2.3yrs	no data	no data
Karina Gehring	Director	less than a year	no data	no data

4.3yrs

Average Tenure

60.5yo

Average Age

Experienced Board: OGI's board of directors are considered experienced (4.3 years average tenure).

Organigram Holdings Management

Management criteria checks 4/4

Key information

Recent management updates

Organigram Holdings Inc. Appoints Karina Gehring as Director and Announces Composition of Committees

Organigram Holdings Inc Announces Chief Financial Officer Changes

Organigram Holdings Inc. Announces CFO Changes

Organigram Holdings Inc. Announces CFO Changes

Organigram Holdings Inc., Annual General Meeting, Jan 15, 2024

Organigram Holdings Inc. Announces Resignation of Ms. Caroline Ferland as Board Member

Recent updates

Organigram: Operating In A Structurally Challenged Industry

Organigram Holdings Inc. has completed a Composite Units Offering in the amount of CAD 25.0002 million.

Organigram Holdings Inc. Receives Health Canada’S Final Redetermination on Jolts

Organigram Holdings Inc. to Report Q1, 2024 Results on Feb 13, 2024

Organigram Holdings Inc. Appoints Karina Gehring as Director and Announces Composition of Committees

Organigram Holdings Inc Announces Chief Financial Officer Changes

Organigram Holdings Inc. to Report Q4, 2023 Results on Dec 19, 2023

Organigram Holdings Inc. Announces CFO Changes

Organigram Holdings Inc. Announces CFO Changes

Organigram Holdings Inc., Annual General Meeting, Jan 15, 2024

Organigram Holdings Inc. Announces Resignation of Ms. Caroline Ferland as Board Member

Organigram Holdings Inc. Launches First Range of THCV Products Derived from Moncton-Grown Whole Flower

Organigram Relaunches One of Canada's First Cannabis Brands, Trailblazer

Organigram Holdings Inc. Launches New Tube-style Pre-rolls: SHRED Dartz and Holy Smokes

Organigram Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of 2023

Organigram Holdings Inc. to Report Q3, 2023 Results on Jul 13, 2023

Organigram Completes Share Consolidation to Ensure the Company Continues to Comply with Nasdaq Listing Requirements

New major risk - Shareholder dilution

New minor risk - Share price stability

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Organigram Holdings Receives Non-Compliance Notice from Nasdaq

Organigram Holdings Inc. Provides Earnings Guidance for the Second Quarter and Full Year of Fiscal 2023

First quarter 2023 earnings: EPS exceeds analyst expectations

Organigram Holdings Inc. to Report Q1, 2023 Results on Jan 12, 2023

Organigram Holdings Inc., Annual General Meeting, Feb 28, 2023

OrganiGram Holdings Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended August 31, 2022

Organigram Holdings Inc. Launches Holy Mountain to Further Support Its Strong Position in the Dried Flower and Hash Categories

OrganiGram Holdings Inc. to Report Q4, 2022 Results on Nov 28, 2022

High number of new directors

Forecast to breakeven in 2025

Don't Rule Out A Bull Market (Podcast Transcript)

Don't Rule Out A Bull Market

Price target decreased to US$2.42

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

OrganiGram Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of Fiscal Year 2022

Organigram revenue of $38.12M beats by $12.05M, sees Q4 revenue higher than Q3

OrganiGram Holdings Inc. to Report Q3, 2022 Results on Jul 14, 2022

Organigram Holdings Inc. Reaches Proposed Settlement

High number of new directors

OrganiGram: Canadian Cannabis Remains Tough To Own

Second quarter 2022 earnings: Revenues in line with analyst expectations

OrganiGram Holdings Inc. Provides Revenue Guidance for the Third Quarter of Fiscal Year 2022

OrganiGram Holdings Inc. to Report Q2, 2022 Results on Apr 12, 2022

No longer forecast to breakeven

OrganiGram Holdings Inc. Announces Board Appointments

Why OrganiGram Should Generate Consistent Growth Going Forward

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Organigram Holdings Inc. Provides Earnings Guidance for the Second Quarter of Fiscal 2022

No longer forecast to breakeven

OrganiGram Holdings Inc. (TSX:OGI) acquired Laurentian Organic Inc. for CAD 35.9 million.

Price target decreased to US$2.73

Full year 2021 earnings: EPS and revenues exceed analyst expectations

OrganiGram Holdings Inc. Provides Revenue Guidance for the First Quarter of 2022

Organigram Holdings Inc Announces the Launch of SHRED’ems

Organigram Holdings Inc.Launches Cannabis Innovators Panel

Third quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.51 loss in 3Q 2020)

OrganiGram Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of 2021

OrganiGram: Positive Signs, But Struggles Persist

OrganiGram Holdings (OGI) Investor Presentation - Slideshow

Organigram Launches Big Bag o’ Buds Indoor-grown, Strain-specific Dried Flower in 28g Value Format

Organigram CEO Greg Engel to step down

OrganiGram: The Hype Is Over

OrganiGram Holdings Inc. Provides Revenue Guidance for the Third Quarter of 2021

Second quarter 2021 earnings released: CA$0.28 loss per share (vs CA$0.041 loss in 2Q 2020)

OrganiGram Holdings Inc. announced that it has received CAD 221.0736 million in funding from British American Tobacco p.l.c.

Organigram Holdings Inc. Launches SHRED Tropic Thunder Jar of J’s (Jar of Joints) and Trailblazer SNAX Milk Chocolate Bars

Senior Vice President of Operations Matt Rogers has left the company

Organigram Holdings Inc. Announces Executive Changes

New 90-day high: US$1.91